Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer.
Tazawa H, Kuroda S, Hasei J, Kagawa S, Fujiwara T. Tazawa H, et al. Among authors: hasei j. Int J Mol Sci. 2017 Jul 10;18(7):1479. doi: 10.3390/ijms18071479. Int J Mol Sci. 2017. PMID: 28698504 Free PMC article. Review.
Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma.
Mochizuki Y, Tazawa H, Demiya K, Kure M, Kondo H, Komatsubara T, Sugiu K, Hasei J, Yoshida A, Kunisada T, Urata Y, Kagawa S, Ozaki T, Fujiwara T. Mochizuki Y, et al. Among authors: hasei j. Cancer Immunol Immunother. 2021 May;70(5):1405-1417. doi: 10.1007/s00262-020-02774-7. Epub 2020 Nov 5. Cancer Immunol Immunother. 2021. PMID: 33151368 Free PMC article.
Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression.
Sugiu K, Tazawa H, Hasei J, Yamakawa Y, Omori T, Komatsubara T, Mochizuki Y, Kondo H, Osaki S, Fujiwara T, Yoshida A, Kunisada T, Ueda K, Urata Y, Kagawa S, Ozaki T, Fujiwara T. Sugiu K, et al. Among authors: hasei j. Cancer Chemother Pharmacol. 2021 Sep;88(3):513-524. doi: 10.1007/s00280-021-04310-5. Epub 2021 Jun 10. Cancer Chemother Pharmacol. 2021. PMID: 34114067 Free article.
33 results